Laird Law broadens access to long-acting HIV prevention medicine
核心洞察
Governor Gavin Newsom signed Senate Bill 1023, expanding reimbursement pathways for long-acting injectable HIV pre-exposure prophylaxis (搜索) in California.
The law requires health plans that already cover injectable PrEP to offer reimbursement through the outpatient prescription drug benefit.
Supporters say the change removes administrative and financial barriers that limited community clinics and smaller providers from offering the six-monthly injection.
California Governor Gavin Newsom signed Senate Bill 1023, legislation by Senator John Laird that expands access to long-acting injectable HIV pre-exposure prophylaxis (搜索) (PrEP). The law requires health plans that already cover injectable PrEP to offer reimbursement through their outpatient prescription drug benefit, rather than limiting coverage to the medical benefit billing pathway.
The medical benefit route is more administratively complex, requiring providers to purchase medications up front and hire specialized staff to manage reimbursement claims. Long-acting injectable PrEP can be administered as infrequently as once every six months, an option for patients who face barriers to daily oral medication. SB 1023 is intended to make it easier for community clinics and smaller health care providers to offer the injectable product.
The bill is a California Legislative LGBTQ Caucus priority and is co-sponsored by Insurance Commissioner Ricardo Lara and the California Department of Insurance (搜索), the San Francisco AIDS Foundation (搜索), Equality California (搜索), APLA Health (搜索), and the Los Angeles LGBT Center. SB 1023 takes effect January 1, 2027.
Source: New Laird Law Expands Access to Long-Acting HIV Prevention Medicine